Pain Management

A breakout session at the Cancer Center Survivorship Research Forum focused on the value of cancer rehabilitation for both patients and oncologists.

Lower back pain remains the leading global cause of years lived with disability, while projections estimate that more than 800 million people will experience lower back pain by 2050, according to data published in The Lancet Rheumatology.

The risk for theoretical opioid addiction affected some patients’ choice of pain medications after Mohs micrographic surgery, according to a study.

AUSTIN, Texas — Significant improvement was reported in children who have follow-up visits to a headache clinic, although Black patients and patients on Medicaid were less likely to complete these visits, according to data presented here.

AUSTIN, Texas — A combination of THC and CBD administered via vaporization was beneficial in migraine treatment, relieving pain and patients’ most bothersome symptoms, according to a study presented here.

DESTIN, Fla. — Significantly more research into the risks and benefits of cannabinoids is necessary to keep pace with both medicinal and recreational use in the U.S., noted a presenter at the 2023 Congress of Clinical Rheumatology-East.

BOSTON — Intranasal Zavzpret was safe and effective for acute treatment of migraine, providing pain relief as early as 15 minutes after administration, according to a presenter at the American Academy of Neurology annual meeting.

The FDA has granted clearance to Neuspera Medical for its novel implantable system to treat chronic peripheral nerve pain.

Patients with fibromyalgia were at greater risk for pain-related exacerbations of opioid use disorder, according to a study published in Pain.

Hyperbaric oxygen therapy improved pain symptoms, quality of life and social and emotional function in adults with fibromyalgia after traumatic brain injury compared with pharmacologic intervention, according to research in PLOS One.